MUC1 and colorectal carcinoma: Premalignant tumors, like colon polyps and pancreatic neoplasms, that progress to form CRC and pancreatic ductal adenocarcinoma have been reported to overexpress MUC1 antigen and, hence, it is a potential antigen to target for immunoprevention [153,154].